Dividends CalendarEarnings Calendar
ZYNE

ZYNE | Zynerba Phamaceuticals Inc

Zynerba Phamaceuticals Inc
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Devon, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 100.35M
  • Prev closed: 4.73
  • Open: 4.95
  • High: 4.95
  • Low: 4.57
  • 52 week low: 2.55
  • 52 week high: 15.7
  • Dividends:No Dividends

Next ER: November 9, 2020  Before Market Opens



Top Stories (ZYNE)

    Company Profile

    Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 9, 2020-0.31 / -0.43- / -
    August 10, 2020-0.78 / -0.45- / -
    May 11, 2020-0.53 / -0.5- / -
    March 19, 2020- / -0.5- / -
    November 14, 2019- / -0.53- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 20, 2020 4.22 4.15
    4.32
    4.08
    656.40K 3.43%
    Nov 19, 2020 4.08 3.92
    4.14
    3.90
    841.41K 5.43%
    Nov 18, 2020 3.87 3.88
    3.95
    3.80
    259.53K -0.26%
    Nov 17, 2020 3.88 3.82
    3.93
    3.80
    519.36K 1.04%
    Nov 16, 2020 3.84 3.86
    3.90
    3.75
    310.83K 1.05%
    Nov 13, 2020 3.80 3.77
    3.95
    3.76
    1.38M 1.33%
    Nov 12, 2020 3.75 3.74
    3.90
    3.66
    738.56K -0.79%
    Nov 11, 2020 3.78 3.76
    3.83
    3.40
    770.82K 1.07%
    Nov 10, 2020 3.74 3.70
    3.80
    3.57
    479.67K 1.63%
    Nov 9, 2020 3.68 3.94
    3.97
    3.55
    651.69K -1.34%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:28

    News

    News for (ZYNE)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Armando Anido
    • General Counsel :  Suzanne M. Hanlon
    • Chief Medical Officer :  Joseph M. Palumbo (Md, Fapa, Macpsych)

    Talk about Zynerba Phamaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 9, 2020 (Same day)

    mcd hain spg icpt btu iii unit mwa zyne cara tlry acb 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    s kmx lrcx bks etr sptn schw agn vips xray veev roku 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.